Viewing Study NCT00486668

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-03-14 @ 11:16 PM
Study NCT ID: NCT00486668
Status: UNKNOWN
Last Update Posted: 2016-06-06
First Post: 2007-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Sponsor: NSABP Foundation Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Invasive Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2 positive breast cancer View
None invasive breast cancer View
None lapatinib View
None neoadjuvant View
None NSABP View
None paclitaxel View
None trastuzumab View
None doxorubicin View
None cyclophosphamide View